Carrie Blades
Emergency Medicine · Cypress, TXNPI 1992794333
Payments from drug & device makers
Across 164 payments — averaging $16.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- Merz North America, Inc.$811
- Corcept Therapeutics$145
- Galderma Laboratories, L.p.$114
- AbbVie$113
- Lilly USA, LLC$64
- plus $245 from 8 others
What the payments were for
- Food & beverage$2,59997%
- Education$703%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 113 | $1,177 |
| Merz North America, Inc. | 14 | $811 |
| Corcept Therapeutics | 5 | $145 |
| Galderma Laboratories, L.p. | 7 | $114 |
| AbbVie(2 entities) | 6 | $113 |
| Lilly USA, LLC | 4 | $64 |
| Revance Therapeutics, Inc. | 2 | $50 |
| AstraZeneca | 3 | $47 |
| Antares Pharma, Inc. | 3 | $44 |
| Vivus LLC | 2 | $31 |
| Acella Pharmaceuticals, LLC | 2 | $30 |
| Eisai Inc. | 1 | $17 |
| Tactile Systems Technology Inc | 1 | $15 |
| Currax Pharmaceuticals LLC | 1 | $12 |
How this compares
$2,669 in reported general payments places this provider in the 95th percentile of 3,952 emergency medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 13 | $21,256 |
| ProgesteroneProgesterone, Micronized | 58 | $3,186 |
| Armour ThyroidThyroid,pork | 16 | $1,678 |
| Testosterone Cypionate | 15 | $1,323 |
| Np ThyroidThyroid,pork | 18 | $1,223 |
| Estradiol | 54 | $1,132 |
| Spironolactone | 23 | $355 |
| Metformin Hcl ErMetformin Hcl | 29 | $327 |
| Liothyronine Sodium | 11 | $313 |
| Levothyroxine Sodium | 25 | $193 |
| Hydroxychloroquine Sulfate | 11 | $112 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $1,177 | $21,25613 claims |
| AbbVieArmour Thyroid | $113 | $1,67816 claims |
| Acella Pharmaceuticals, LLCNp Thyroid | $30 | $1,22318 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,952 emergency medicine providers in Texas.
Other emergency medicine in Cypress
- Chad CrystalPalestine$26.8M
- Brian SpearsSan Antonio$12.9M
- Sinikka GreenAustin$10.2M
- James LillyDallas$8.5M
- Craig BoyleAustin$8M
- Alan HandSugar Land$6.8M
- Rebecca Wood-HorrallSmithville$5.9M
- Michael ZimmermanAustin$4.7M
- Bentley BobrowHouston$2.7M
- David WatsonFort Hood$2.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.